• Home
  • Research
  • The Efficacy and Tolerability of FuFang DanShen for Uncontrolled Hypertension

American Association of Acupuncture and Oriental Medicine

We serve to advance the profession and practice of AOM

The statements and opinions contained in the articles on the American Association of Acupuncture and Oriental Medicine's (AAAOM) Blog are solely those of the individual authors and contributors and not of the AAAOM. The appearance of advertisements in the AAAOM’s publications are not a warranty, endorsement or approval of the products or their safety. The AAAOM disclaims responsibility for any loss, injury or damage to persons or property resulting from any ideas or products referred to in any article or advertisement. Readers are advised to verify any information on which they choose to rely. 


The Efficacy and Tolerability of FuFang DanShen for Uncontrolled Hypertension

06 Sep 2016 2:01 PM | Anonymous

09/02/2011 - THE EFFICACY AND TOLERABILITY OF FUFANG DANSHEN (SALVIA MILTIORRHIZA) AS ADD-ON ANTIHYPERTENSIVE THERAPY IN TAIWANESE PATIENTS WITH UNCONTROLLED HYPERTENSION

Posted By Administration, Friday, September 02, 2011
Updated: Wednesday, July 16, 2014

[NIH] Hypertension generally requires the use of a combination therapy to achieve the satisfactory control of blood pressure. A traditional Chinese herb, Danshen (Salvia miltiorrhiza), has been shown to have cardioprotective effects in animals and humans. The study investigated the add-on effect of Fufang Danshen extract capsule in Taiwanese hypertensive patients with uncontrolled blood pressure. This was a double-blind, placebo-controlled, randomized, single-center study clinical trial. Fifty-five patients with uncontrolled mild to moderate hypertension were enrolled under current conventional antihypertensive treatment, randomized equally to receive a Fufang Danshen capsule (formula mixture) 1000 mg twice-daily or a placebo capsule for 12 weeks. Primary endpoints were the control rate and the response rate. By ITT analysis at week 12, the control rates were 25.5% in the Fufang Danshen group and 7.3% in the control group (p = 0.016). The response rates were 45.6% in the Fufang Danshen group and 38.2% in the placebo group (p = 0.946). A significant reduction of systolic blood pressure at week 12 was noted in the Fufang Danshen group compared with the placebo group (13.8 vs 4.2 mmHg, p = 0.005). A decrease of pulse rate was also noted in the Fufang Danshen group (- 3.2 vs +2.7/min, p = 0.027). Adverse events were not statistically different between the two groups. It was concluded that Fufang Danshen (Salvia miltiorrhiza) extract reduced systolic blood pressure and pulse rate, and was well tolerated in patients with hypertension.

http://www.ncbi.nlm.nih.gov/pubmed/21887804#



   acupuncture website design                                                                     

                                                                                                                 
                      
   


PO Box 96503 #44114, Washington DC 20090-6503

Reach us at admin@aaaomonline.org

Powered by Wild Apricot Membership Software